AT460938T
Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
Abstract
This record has no abstract on file.
Term
Term ended
Expired 2 December 2023, 2.8 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
71 members in 45 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 0228787 | United Kingdom | A | |
| 0308460 | United Kingdom | A | |
| 0313606 | United Kingdom | A | |
| 0305683 | International Bureau of the World Intellectual Property Organization (WIPO) | W |
Members71
| Document | Office | Kind | |
|---|---|---|---|
| US976199A | United States of America | A | |
| GB0228787D0 | United Kingdom | D0 | |
| GB0308460D0 | United Kingdom | D0 | |
| GB0313606D0 | United Kingdom | D0 | |
| NL1024983A1 | Netherlands (Kingdom of the) | A1 | |
| CA2508262A1 | Canada | A1 | |
| WO2004052372A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003302878A1 | Australia | A1 | |
| UY28117A1 | Uruguay | A1 | |
| GT200300277A | Guatemala | A | |
| TW200423944A | Taiwan Province of China | A | |
| HN2003000401A | Honduras | A | |
| PA8591601A1 | Panama | A1 | |
| US2004259874A1 | United States of America | A1 | |
| PE20040906A1 | Peru | A1 | |
| NL1024983C2 | Netherlands (Kingdom of the) | C2 | |
| IS7843A | Iceland | A | |
| NO20052557D0 | Norway | D0 | |
| AR042339A1 | Argentina | A1 | |
| AP2005003325A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| CR7869A | Costa Rica | A | |
| MXPA05006151A | Mexico | A | |
| HRP20050523A2 | Croatia | A2 | |
| NO20052557L | Norway | L | |
| EP1572214A1 | European Patent Office (EPO) | A1 | |
| ECSP055850A | Ecuador | A | |
| KR20050094813A | Republic of Korea | A | |
| BR0317102A | Brazil | A | |
| MA27605A1 | Morocco | A1 | |
| EA200500801A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN1723023A | China | A | |
| PL377480A1 | Poland | A1 | |
| JP2006511599A | Japan | A | |
| HK1081850A | Hong Kong, China | A | |
| HK1081850A1 | Hong Kong, China | A1 | |
| ZA200504727B | South Africa | B | |
| JP2006232857A | Japan | A | |
| US2006235016A1 | United States of America | A1 | |
| OA13014A | African Intellectual Property Organization (OAPI) | A | |
| CO5700781A2 | Colombia | A2 | |
| NZ540505A | New Zealand | A | |
| JP3889775B2 | Japan | B2 | |
| JP2007084575A | Japan | A | |
| RS20050445A | Serbia | A | |
| UA79024C2 | Ukraine | C2 | |
| TNSN05159A1 | Tunisia | A1 | |
| JP3920908B2 | Japan | B2 | |
| GEP20074272B | Georgia | B | |
| KR100796102B1 | Republic of Korea | B1 | |
| US7323462B2 | United States of America | B2 | |
| CN101117335A | China | A | |
| EA009589B1 | Eurasian Patent Organization (EAPO) | B1 | |
| AU2003302878B2 | Australia | B2 | |
| CN100488510C | China | C | |
| US7576081B2 | United States of America | B2 | |
| US2009270384A1 | United States of America | A1 | |
| CA2508262C | Canada | C | |
| EP1572214B1 | European Patent Office (EPO) | B1 | |
| AT460938TThis record | Austria | T | |
| ATE460938T1 | Austria | T1 | |
| DE60331769D1 | Germany | D1 | |
| PT1572214E | Portugal | E | |
| ES2339767T3 | Spain | T3 | |
| DK1572214T3 | Denmark | T3 | |
| SI1572214T1 | Slovenia | T1 | |
| JP4624341B2 | Japan | B2 | |
| NO330143B1 | Norway | B1 | |
| US7902188B2 | United States of America | B2 | |
| RS51442B | Serbia | B | |
| MY144338A | Malaysia | A | |
| CY1110130T1 | Cyprus | T1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 3812639
Titles2
- German
- MORPHOLIN-DERIVATE ZUR VERWENDUNG ALS DOPAMINAGONISTEN IN DER BEHANDLUNG VON U.A. SEXUELLER DYSFUNKTION
- English
- MORPHOLIN DERIVATIVES FOR USE AS DOPAMINAGONISTS IN THE TREATMENT OF SEXUAL DYSFUNCTION
Classification
- CPC, 21
- C07D265/30
- A61P1/04
- C07D413/04
- A61P1/14
- A61P3/04
- A61P9/00
- A61P9/12
- A61P15/00
- A61P15/08
- A61P15/10
- A61P17/14
- A61P25/00
- A61P25/06
- A61P25/16
- A61P25/18
- A61P25/20
- A61P25/22
- A61P25/24
- A61P25/28
- A61P25/30
- A61P43/00
- IPC, 5
- A61K31 5375
- A61K31 5377
- A61P15 00
- C07D265 30
- C07D413 04